Alverium Health, an innovation in the journey from scientific ambition to commercial reality, is a contract biotech company, led by a highly experienced, functionally diverse team dedicated to creating maximum value for assets, companies and patients through a unique approach to the commercialization journey
An innovation in the journey
from scientific ambition
to commercial reality
The typical drug discovery timeline is lengthy, costly and risky. The average cost to bring an asset to market has increased by 67% since 2010. The average cost to develop a therapeutic asset is estimated at $1.3bn.
LSE, LSH&TM and KUL (2020)
Good science, lots of discovery and record funding levels should lead to unlimited potential.
Yet, every year real dollars and value are lost through unmet expectations.
Turning the unrealized opportunity into value is what Alverium was designed to achieve.
“Translating scientific ambition into full commercial potential… ”
We can strategically drive and executionally direct an integrated process to accelerate the journey from concept to commercialization and beyond.
For individuals or organizations who want a more agile and efficient approach to bringing assets to market, while maintaining optionality for individual and corporate goals, we can engage at any stage of the journey to build value with our global strategy and delivery team.
We enable a higher confidence level for commercial success and patient benefit because we:
that focus on what is
needed to enhance
guide the asset
with a seasoned
A highly experienced, functionally diverse team dedicated to creating maximum value for assets, companies and patients through a unique approach to the commercialization journey
Commercial GTM Strategy,
Plans & Execution
Concept Inception & Evolution
Clinical Development Process
Commercial GTM Strategy, Plans & Execution:
We develop strategy and follow it through to tactical plans and execution. Our model augments or replaces internal functions and resources, accelerating progress with cost flexibility and minimal executional complexity, while ensuring corporate runway optionality.
Functional integration adds
value at every stage of the process
Most time is lost here...
you never get this time back...
Our integrated team will meet the client wherever they are in their journey
Deep integrated expertise, building value at every step
Shared Risk of Developing
the Client’s Asset
One partner to deliver an asset from discovery to a regional and or global market: avoids the need to engage multiple expert consultants and the struggle to connect them all
Alverium Engagement Experience sits above traditional customer experience: and is paramount from beginning to end; not a separate concept introduced in late-stage commercialization.
Doers not just advisers: Alverium does not just advise a client on how it should/can bring an asset to a global market; Alverium will do it with/for the client
All execution is strategically connected and directed: early involvement of all functional areas and ongoing seamless integration ensures faster time to market and optimal launch performance; no disconnects, no sloppy hand-offs, no competing agendas.
Novel platform strategy
Newly formed cannabinoid platform biotech needed to accelerate clinical to commercial program.
In 4 months, added an exec team that rebranded the company, reprioritized therapeutic focus, evolved clinical development program and launched a raise.
Emerging biotech bringing therapies to market in the UK and US needed support for a variety of pre-launch activities to meet timelines.
Deployed on-demand team to support key projects from clinical to commercial globally.
Fail fast to pivot
Emerging founder/owner clinical organization of 30, moving to commercial quickly with a novel product used in the ICU.
Immediately inserted clinical to commercial leadership team and brought them to P3 results sooner, which failed. De-risked model allowed them to quickly pivot to focus on their next pipeline asset with minimal cost and operational issues.
Founder & CEO
A C-level industry expert with 25+ years dedicated to corporate growth leadership. Exceptional experiences range from early clinical development through commercialization for the pharmaceutical, biotech, and device sectors. With a patient centric focus, ongoing achievements are based on delivering consistent, above market growth for global and regional initiatives, corporate marketing, and complete life cycle brand management.
Founder & CFO
Skilled at transforming complex business scenarios into more understandable concepts for stakeholders. Experienced at leading, educating, supporting, and guiding clients as they develop and implement strategic business and investment plans. Areas of specialty include business strategy, acquisitions, start-ups, business development, business modelling, financial management and corporate recovery.
Global Commercial and Corporate Strategy Advisor
Proven commercial leader with 25+ years of successfully building business value and organizational capability. Strength in developing insight-based strategic foundations to accelerate revenue, profit, and share growth on both new launches and mature industry-leading global brands. Experience across the pharmaceutical and over-the-counter healthcare markets includes portfolio P&L management, business strategy, marketing research, and product innovation.
Darren Rubin, MS, MBA
Chief Science and Regulatory Strategy Advisor
Entrepreneur and former Chief Science Officer responsible for orphan drugs and other new drug product approvals, regulatory and clinical strategy, licensing, and Paragraph IV challenges. Expertise includes Biochemistry and Molecular Biology within multiple therapeutic areas including Oncology, Neurology, Cardiovascular, and Respiratory.
Dr. Bradley Chipps
Chief Medical Officer & Clinical Advisor
Board certified in pediatric pulmonology and allergy and clinical immunology. Currently, Medical Director of respiratory therapy and the cystic fibrosis center at Sutter Medical Center in Sacramento. Established the Sutter Community Hospitals Sleep Laboratory in 1984 and continues to serve as Associate Medical Director. Previously, served on the program committees for both the American Thoracic Society and the AAAAI and is a member of all the major respiratory societies.
Global Advocate Development Strategy Advisor
A global healthcare expert with 38 years of experience in building and facilitating enduring advocate networks on behalf of R&D, Medical and Commercial programs supporting new and innovative product offerings.
Bina Green, MBA
Digital Strategy Advisor
An expert in defining and delivering digital solutions to support business strategies. A senior digital executive with solid stakeholder management skills and an endless commitment to excellence. A goal driven thought leader with a track record of successfully developing and deploying comprehensive initiatives within challenging environments. Known for her regional and global leadership strength and cross-functional team successes.
Natalie Sandstedt, MBA
Bringing 30 years of commercial pharmaceutical experience that bridges across professional and patient promotion, and marketplace development. Having worked for both manufacturers and advertising agencies, proficiency is rooted in Marketing, Market Research, Sales, Sales Training and Managed Markets. Experience includes leading 16 brands, seven therapeutic areas (including rare diseases) and pre-launch, launch and post-launch excellence.
Martin Jernigan, RPh, PhD
Over 25 years of U.S. and global cross-functional and commercial teams experience. Expertise is founded in Lifecycle Management for billion-dollar brands from pre-launch throughout the entirety of commercialization. Additional areas of mastery include Licensing, Business Development, Alliance Management, Marketing, Sales, and Market Access. Experience is complimented with a PhD in Healthcare Administration, concentration in Pharmaceutical Marketing.
A business and marketing leader with 30+ years of domestic and international experience in medical technology, pharmaceuticals and biotechnology. Proven track record as a cross-functional leader in various companies including executive roles leading the healthcare practice at two marketing and public relations agencies. Currently co-founder, president and CEO of Invisian Medical, a specialty surgical medical device company and operating partner and board member for two medical device platforms with Shore Capital Partners.
More than 20 years of global creative experience on 50+ brands in the healthcare sector across European, U.S and global markets. Leads creative approach and integration from clinical to commercialization synthesizing advertising, public relations and medical education creative and design solutions. Served as jury member for prestigious creative award shows including Cannes Lions Health & Wellness, The New York Festivals Global Awards, The Clio Health Awards and Eurobest.
Project Management Officer
Over three decades of experience in establishing PMO organizations, driving strategies, process engineering and innovations to address consumerisation and digital transformation in technology and retail spaces, including performance marketing, CXM, CRM and retail activation. Proven success in matrix managing cross functional teams with internal and external partnerships while managing PMOs in Fortune 20 companies. LSSBB [Lean Six Sigma Black Belt] and CSM [Certified Agile SCRUM Master] with a published patent in the area of Strategic Supplier Performance Management. Experience in RPA, AI and Cognitive Learning to drive digital transformation and innovation.
Finance & Project Management Advisor
20 years of experience developing and leading high-performance teams from education to collegiate sports to financial planning. Experienced in operational excellence in both financial and commercial environments, as well as project management for highly complex programs.
Alverium executive team administration support focusing on scheduling, calendar management and prioritizing critical path activities. Key contact for client, prospects and team members regarding executive’s time and resources. Manages team calendars and external client communications regarding calls, conferences, and events.